Journal of Animal and Veterinary Advances

91
Views

1
Downloads

Hypotheses: A New Way Against Cancer Metastasis, Chitooligosaccharides as Mucosal Adjuvant for Therapeutic Vaccination Targeting Heparanase

Haizhi Quan and Zirong Xu
Page: 2788-2791 | Received 21 Sep 2022, Published online: 21 Sep 2022

By Research Area

Medicine & Public Health Life Sciences Engineering Mathematics Biomedicine Physics Chemistry Computer Science Earth Sciences Social Sciences Business and Management Psychology Materials Science Economics Education Environment Philosophy Statistics Law Political Science and International Relations Pharmacy Dentistry Energy Linguistics Geography Finance Criminology and Criminal Justice Medicine Cultural and Media Studies History Architecture / Design Literature Biomedical Sciences Religious Studies Education & Language Food Science & Nutrition Public Health

By Volume and Issue

Abstract

Heparanase is a tumor metastasis associated antigen so cancer vaccine targeting heparanase is an effective way to treat tumor metastasis. However, cancer vaccine needs adjuvant because of low immunostimulatory. Chitooligosaccharides (COS) has been proved to be an successful cancer vaccine adjuvant due to its propertied. COS will be a well adjuvant for cancer vaccine targeting heparanase.

How to cite this article:

Haizhi Quan and Zirong Xu. Hypotheses: A New Way Against Cancer Metastasis, Chitooligosaccharides as Mucosal Adjuvant for Therapeutic Vaccination Targeting Heparanase.
DOI: https://doi.org/10.36478/javaa.2012.2788.2791
URL: https://www.makhillpublications.co/view-article/1680-5593/javaa.2012.2788.2791